The AstraZeneca vaccine against Covid-19, manufactured in South Korea and India, has been officially approved by the World Health Organization (WHO). The product developed by this company has also been authorized by the Australian authorities.
The World Health Organization has announced that the vaccine has been approved under an accelerated procedure and will be available under the Covax program. It aims to provide the drug to developing countries where human immunization has been a major problem so far.
A total of 336 million doses could be produced and distributed in the first two quarters of this year.
At the same time, the Australian authorities have confirmed that the vaccine, developed by AstraZeneca and the University of Oxford, meets strict safety, quality and efficacy standards. It will be able to vaccinate people from the age of 18.
At the same time, the regulator indicated that there will still be discussions about the immunization of seniors with this drug.
In advance WHO announcedthat the Covid-19 vaccine, developed by Oxford University and AstraZeneca, is also safe for people over 65 years of age. The WHO believes that this vaccine can also be used against the new types of Covid-19.
AstraZeneca is the third vaccine approved by the European Commission for use in the European Union. Although the European Medicines Agency recommends the vaccine to all people over the age of 18, due to a lack of data, several European countries do not yet plan to use it in the elderly.
Highlight text and press Ctrl+Enterto send the text to be edited!
Highlight text and press Report a bug buttons to send the text to be edited!